Common in-lab, marker-based gait analyses may not represent daily, real-world gait. Real-world gait analyses may be feasible using inertial measurement units (IMUs), especially with recent advancements in open-source methods (e.g., OpenSense). Before using OpenSense to study real-world gait, we must determine whether these methods: (1) estimate joint kinematics similarly to traditional marker-based motion capture (MoCap) and (2) differentiate groups with clinically different gait mechanics. Healthy young and older adults and older adults with knee osteoarthritis completed this study. We captured MoCap and IMU data during overground walking at self-selected and faster speeds. MoCap and IMU kinematics were computed with appropriate OpenSim workflows. We tested whether sagittal kinematics differed between MoCap- and IMU-derived data, whether tools detected between-group differences similarly, and whether kinematics differed between tools by speed. MoCap data showed more flexion than IMU data (hip: 0-47 and 65-100% stride, knee: 0-38 and 58-91% stride, ankle: 18-100% stride). Group kinematics differed at the hip (young extension > knee osteoarthritis at 30-47% stride) and ankle (young plantar flexion > older healthy at 62-65% stride). Group-by-tool interactions occurred at the hip (61-63% stride). Significant tool-by-speed interactions were found, with hip and knee flexion increasing more for MoCap than IMU data with speed (hip: 12-15% stride, knee: 60-63% stride). While MoCap- and IMU-derived kinematics differed, our results suggested that the tools similarly detected clinically meaningful differences in gait. Results of the current study suggest that IMU-derived kinematics with OpenSense may enable the valid and reliable evaluation of gait in real-world, unobserved settings.

The authors have declared no competing interest.

This study did not receive any funding

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

University of Michigan Institutional Review Board, protocol HUM00139075

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

All data produced in the present study are available upon reasonable request to the authors. Some data and code used in this work are available at https://simtk.org/projects/knee-oa-age-imu.

https://simtk.org/projects/knee-oa-age-imu